A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
M. Lebwohl
and Others
- 20 Nov, 2003
This
PowerPoint Slide Set is a value
added service that requires an individual subscription.
Already a print subscriber? Activate your online access
Not a Subscriber?
Get full access to NEJM Online now with a FREE TRIAL!
Or, purchase full access to this
PowerPoint Slide Set for $10
